IL10 and neoplasm: Upon tumor colonization, the immunogenicity of DB1 activated Toll‐like receptor 4 (TLR4) signaling in tumor‐associated macrophages (TAMs), promoting interleukin‐10 (IL‐10) secretion and reshaping the tumor immune microenvironment.